Takeda Pharmaceutical Company Limited
Ticker
TAK
ISIN
US874060205
Price
USD 13.29
Change Today
-0.33 / -2.423 %
Price 1 year ago
13.72 / -3.134 %
Market Capitalization
42,708,844,544.00
52 Week Low
12.60
52 Week High
15.08
200 Day Moving Average
13.90
50-day Moving Average
14.16
Price evolution
Yearly Returns
Peers
Peers
Company information
Summary
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab, Alofisel, Dexilant, Natpara, Adynovate/Adynovi, Takhzyro, Livtencity, Elaprase, Replagal, Advate, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, Velcade, Leuplin/Enantone, Adcetris, Vyvansese, Trintellix, and Alunbrig brands. Takeda Pharmaceutical Company Limited has out-licensing agreement with Neurocrine Biosciences, Inc.; collaborations and in-licensing agreements with the University of Texas MD Anderson Cancer Center, Arrowhead Pharmaceuticals Inc., and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., as well as a licensing agreement with ProThera Biologics Inc. It also has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, Selecta Biosciences, BridGene Biosciences, Skyhawk Therapeutics, and StrideBio; and strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Country
Japan
Exchange
NYQ
Earnings Per Share
0.526
P/E Ratio
26.064638
Debt/Equity Ratio
72.851
Beta
0.807379
Ebitda
1,043,873,005,568.00
Ebitda Margins
0.29
Enterprise to Ebitda
3.83
Enterprise Value
4,001,990,967,296.00
Target Price
19.13
Estimated Price
-
Book Value
1,482.50
Expected Growth
-
Balance sheet
Income statement
Sustainability
Correlation
Company | Name | Correlation |
---|---|---|
300239.SZ | BAOTOU DONGBAO BIO | -0.59 |
600062.SS | CHINA RESOURCES DOUBLE-CRANE PH | -0.57 |
600277.SS | ELION CLEAN ENERGY CO LTD | -0.49 |
600750.SS | JIANGXI JIANGZHONG PHARMACEUTIC | -0.49 |
300039.SZ | SHANGHAI KAIBAO PH | -0.46 |
300026.SZ | TIANJIN CHASE SUN | -0.43 |
SIDO.JK | Industri Jamu dan Farmasi Sido | -0.35 |
300534.SZ | GANSU LONGSHENRONG | -0.34 |
300199.SZ | HYBIO PHARMACEUTIC | -0.32 |
0460.HK | SIHUAN PHARM | -0.27 |
600380.SS | JOINCARE PHARMACEUTICAL GROUP I | -0.27 |
300158.SZ | SHANXI ZHENDONG PH | -0.24 |
300142.SZ | WALVAX BIOTECHNOLO | -0.17 |
HLN.L | HALEON PLC | -0.07 |
300110.SZ | HUAREN PHARMACEUTI | -0.07 |
600216.SS | ZHEJIANG MEDICINE | -0.01 |
600196.SS | SHANGHAI FOSUN PHARMACEUTICAL G | 0.08 |
600252.SS | GUANGXI WUZHOU ZHONGHENG GROUP | 0.10 |
600518.SS | KANGMEI PHARMACEUTICAL CO LTD | 0.14 |
300194.SZ | FUAN PHARMACEUTICA | 0.14 |
0570.HK | TRAD CHI MED | 0.16 |
600079.SS | HUMANWELL HEALTHCARE (GROUP) CO | 0.25 |
002001.SZ | ZHEJIANG NHU CO | 0.33 |
TEVA | Teva Pharmaceutical Industries | 0.38 |
MCOA | MARIJUANA COMPANY OF AMERICA IN | 0.42 |
600781.SS | FUREN GROUP PHARMACEUTICAL CO L | 0.44 |
TLRY | Tilray Brands, Inc. - Class 2 | 0.52 |
SFLM | SFLMAVEN CORP | 0.64 |
Similar companies
Ticker | Name | City | Country | Currency | Exchange | Beta | EV/EBITDA | Employees | Site |
---|---|---|---|---|---|---|---|---|---|
MCOA | MARIJUANA COMPANY OF AMERICA IN | Los Angeles | United States | USD | PNK | 1.15 | -1.91 | 7 | https://www.marijuanacompanyofamerica.com |
600277.SS | ELION CLEAN ENERGY CO LTD | Beijing | China | CNY | SHH | 0.81 | 14.08 | 3926 | https://www.elion.cn |
300026.SZ | TIANJIN CHASE SUN | Tianjin | China | CNY | SHZ | -0.10 | 16.16 | https://www.chasesun.cn | |
ENDP | Endo International plc | Dublin | Ireland | USD | NMS | 1.12 | 9.59 | 3103 | https://www.endo.com |
300110.SZ | HUAREN PHARMACEUTI | Qingdao | China | CNY | SHZ | 0.86 | 22.14 | 2242 | https://www.qdhuaren.com |
600518.SS | KANGMEI PHARMACEUTICAL CO LTD | Puning | China | CNY | SHH | 0.26 | -11.18 | 6410 | https://www.kangmei.com.cn |
600062.SS | CHINA RESOURCES DOUBLE-CRANE PH | Beijing | China | CNY | SHH | -0.16 | 12.21 | 11029 | https://www.dcpc.com |
600079.SS | HUMANWELL HEALTHCARE (GROUP) CO | Wuhan | China | CNY | SHH | 0.87 | 13.32 | 15746 | https://www.humanwell.com.cn |
SIDO.JK | Industri Jamu dan Farmasi Sido | Semarang | Indonesia | IDR | JKT | 0.14 | 15.04 | 3081 | https://www.sidomuncul.co.id |
600196.SS | SHANGHAI FOSUN PHARMACEUTICAL G | Shanghai | China | CNY | SHH | 0.65 | 30.59 | 36279 | https://www.fosunpharma.com |
HLN.L | HALEON PLC | Weybridge | United Kingdom | GBp | LSE | 16.31 | 22000 | https://www.haleon.com | |
002001.SZ | ZHEJIANG NHU CO | Xinchang | China | CNY | SHZ | 0.31 | 10.45 | 10805 | https://www.cnhu.com |
0460.HK | SIHUAN PHARM | Wan Chai | Hong Kong | HKD | HKG | 0.61 | 7.15 | 4282 | https://www.sihuanpharm.com |
TLRY | Tilray Brands, Inc. - Class 2 | Leamington | Canada | USD | NMS | -28.58 | https://www.tilray.com | ||
300199.SZ | HYBIO PHARMACEUTIC | Shenzhen | China | CNY | SHZ | 0.02 | -117.98 | 885 | https://www.hybio.com.cn |
0570.HK | TRAD CHI MED | Wan Chai | Hong Kong | HKD | HKG | 0.51 | 5.97 | 17098 | https://www.china-tcm.com.cn |
600216.SS | ZHEJIANG MEDICINE | Shaoxing | China | CNY | SHH | -0.16 | 7.75 | 5901 | https://www.zmc.top |
300194.SZ | FUAN PHARMACEUTICA | Chongqing | China | CNY | SHZ | 0.41 | 15.82 | 3004 | https://www.fapharm.com |
300039.SZ | SHANGHAI KAIBAO PH | Shanghai | China | CNY | SHZ | 0.31 | 32.28 | 1432 | https://www.xykb.com |
300142.SZ | WALVAX BIOTECHNOLO | Kunming | China | CNY | SHZ | 0.62 | 56.64 | https://www.walvax.com | |
300239.SZ | BAOTOU DONGBAO BIO | Baotou | China | CNY | SHZ | 0.26 | 43.88 | 1354 | https://www.dongbaoshengwu.com |
600252.SS | GUANGXI WUZHOU ZHONGHENG GROUP | Wuzhou | China | CNY | SHH | 0.39 | 56.88 | 3453 | https://www.wz-zhongheng.com |
300158.SZ | SHANXI ZHENDONG PH | Changzhi | China | CNY | SHZ | 0.32 | 5.06 | 4123 | https://www.zdjt.com |
600781.SS | FUREN GROUP PHARMACEUTICAL CO L | Shanghai | China | CNY | SHH | 0.27 | -5.14 | 2916 | https://www.shfuren.cn |
ZOM | Zomedica Corp. | Ann Arbor | United States | USD | ASE | 0.59 | -3.10 | 47 | https://www.zomedica.com |
300534.SZ | GANSU LONGSHENRONG | Lanzhou | China | CNY | SHZ | 0.38 | 195.38 | 302 | https://www.lsrfzy.com |
SFLM | SFLMAVEN CORP | Leamington Spa | United Kingdom | USD | PNK | 3.15 | -1.48 | 1 | https://www.dnadynamicsinc.com |
600750.SS | JIANGXI JIANGZHONG PHARMACEUTIC | Nanchang | China | CNY | SHH | 0.40 | 9.25 | 4153 | https://www.jzjt.com |
600380.SS | JOINCARE PHARMACEUTICAL GROUP I | Shenzhen | China | CNY | SHH | 0.66 | 6.07 | 13234 | https://www.joincare.com |
TEVA | Teva Pharmaceutical Industries | Tel Aviv | Israel | USD | NYQ | 1.22 | 7.45 | 34713 | https://www.tevapharm.com |
600521.SS | ZHEJIANG HUAHAI PHARMACEUTICAL | Linhai | China | CNY | SHH | 0.22 | 30.80 | 7019 | https://www.huahaipharm.com |
600664.SS | HARBIN PHARMACEUTICAL GROUP CO | Harbin | China | CNY | SHH | 9.55 | https://www.hayao.com | ||
300401.SZ | ZHEJIANG GARDEN BI | Dongyang | China | CNY | SHZ | -0.24 | 14.95 | 742 | https://www.hybiotech.com |
600568.SS | ZHONG ZHU HEALTHCARE HOLDING CO | Zhuhai | China | CNY | SHH | 0.45 | -231.66 | 1286 | https://www.zz600568.com |
CGC | Canopy Growth Corporation | Smiths Falls | Canada | USD | NMS | 2.23 | -2.61 | 3151 | https://www.canopygrowth.com |
DVLP | GOLDEN DEVELOPING SOLUTIONS INC | Fort Lauderdale | United States | USD | PNK | 1.60 | https://goldendeveloping.com | ||
SIGA | SIGA Technologies Inc. | New York | United States | USD | NGM | 0.40 | 12.13 | 39 | https://www.siga.com |
3320.HK | CHINARES PHARMA | Wan Chai | Hong Kong | HKD | HKG | 0.42 | 9.52 | 65000 | https://www.crpharm.com |
300601.SZ | SHENZHEN KANGTAI B | Shenzhen | China | CNY | SHZ | 0.31 | 17.71 | 2445 | https://www.biokangtai.com |
600267.SS | ZHEJIANG HISUN PHARMACEUTICAL C | Taizhou | China | CNY | SHH | 0.53 | 11.17 | 8280 | https://www.hisunpharm.com |
Funds
Mutual Fund Holders
Social
Dividends
Ratings
News
Earnings
SEC Filings
Options
Indicators
Glossary
- Momentum
- A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
- Inertia
- In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
- Relative Strength Index (RSI)
- A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
- Fibonacci's Weighted Moving Average
- A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
- Williams %R
- A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
- Relative Volatility Index (RVI)
- A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
- Commodity Channel Index (CCI)
- A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.